Skip to main content
Clinical Trials/ISRCTN93749377
ISRCTN93749377
Completed
未知

A preliminary, single-center, prospective, interventional, single-arm study investigating the safety, tolerability and efficacy of Metformin in Romanian adult patients with autosomal dominant polycystic kidney disease

Fundeni Clinical institute0 sites34 target enrollmentFebruary 25, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Autosomal Dominant Polycystic Kidney Disease
Sponsor
Fundeni Clinical institute
Enrollment
34
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/31337351 (added 25/07/2019)

Registry
who.int
Start Date
February 25, 2019
End Date
December 31, 2018
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Fundeni Clinical institute

Eligibility Criteria

Inclusion Criteria

  • 1\. Age \= 18 years
  • 2\. Diagnosis of ADPKD based on unified ultrasonographic Pei\-Ravine criteria
  • 3\. CKD G1\-G5 not on dialysis.

Exclusion Criteria

  • 1\. Diabetes mellitus
  • 2\. Active infections
  • 3\. Pregnant or breastfeeding patients,
  • 4\. Known contraindication or allergy to Metformin
  • 5\. Receiving renal replacement therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials